BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 30783370)

  • 1. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
    Fung BM; Lindor KD; Tabibian JH
    World J Gastroenterol; 2019 Feb; 25(6):659-671. PubMed ID: 30783370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk, screening and surveillance in primary sclerosing cholangitis.
    Chascsa DM; Lindor KD
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):214-228. PubMed ID: 31220911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer surveillance in patients with primary sclerosing cholangitis.
    Razumilava N; Gores GJ; Lindor KD
    Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for malignancy in primary sclerosing cholangitis (PSC).
    Khaderi SA; Sussman NL
    Curr Gastroenterol Rep; 2015 Apr; 17(4):17. PubMed ID: 25786901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
    Fung BM; Tabibian JH
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):487-496. PubMed ID: 33682586
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G; Cristoferi L; Strazzabosco M; Fabris L
    Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent insights in primary sclerosing cholangitis.
    Ponsioen CY
    J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
    Bowlus CL; Lim JK; Lindor KD
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
    Folseraas T; Boberg KM
    Clin Liver Dis; 2016 Feb; 20(1):79-98. PubMed ID: 26593292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis.
    Milkiewicz P; Wunsch E
    Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
    Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
    Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
    Ilyas SI; Eaton JE; Gores GJ
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2152-65. PubMed ID: 26051390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Sclerosing Cholangitis: What the Gastroenterologist and Hepatologist Needs to Know.
    Gossard AA; Gores GJ
    Clin Liver Dis; 2017 Nov; 21(4):725-737. PubMed ID: 28987259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
    Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
    Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.